BSTG Quote, Trading Chart, Biostage
home / stock / bstg / bstg quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-02-23 | 2 | 1.8 | 2 | 1.8 | 4,062 |
| 2021-02-22 | 1.86 | 2 | 2 | 1.86 | 2,094 |
| 2021-02-18 | 1.855 | 1.855 | 1.855 | 1.855 | 303 |
| 2021-02-17 | 1.95 | 1.97 | 1.97 | 1.8 | 4,656 |
| 2021-02-16 | 2.1 | 2.09 | 2.1 | 2.09 | 1,243 |
| 2021-02-11 | 1.82 | 2.12 | 2.19 | 1.81 | 809 |
| 2021-02-10 | 2.1 | 1.82 | 2.1 | 1.82 | 4,292 |
| 2021-02-09 | 2.06 | 1.82 | 2.06 | 1.82 | 525 |
| 2021-02-08 | 1.95 | 1.81 | 1.95 | 1.81 | 1,725 |
| 2021-02-05 | 2 | 2 | 2 | 2 | 1,475 |
| 2021-02-04 | 1.94 | 2.06 | 2.06 | 1.8 | 2,348 |
| 2021-02-03 | 2 | 2 | 2 | 2 | 129 |
| 2021-02-01 | 1.9 | 1.93 | 1.93 | 1.8 | 1,211 |
| 2021-01-29 | 1.79 | 1.8 | 1.81 | 1.79 | 7,338 |
| 2021-01-28 | 1.85 | 1.86 | 2.5 | 1.81 | 15,597 |
| 2021-01-27 | 1.7865 | 1.8 | 1.8 | 1.75 | 2,301 |
| 2021-01-26 | 1.56 | 1.8 | 1.8 | 1.53 | 2,452 |
| 2021-01-25 | 1.52 | 1.52 | 1.52 | 1.52 | 126 |
| 2021-01-22 | 1.485 | 1.45 | 1.485 | 1.45 | 441 |
| 2021-01-21 | 1.44 | 1.52 | 1.56 | 1.44 | 1,501 |
News, Short Squeeze, Breakout and More Instantly...
-
Biostage Strengthens Board of Directors with Appointment of Herman Sanchez PR Newswire HOLLISTON, Mass. , Jan. 25, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal ...
-
Biostage Reports Third Quarter 2020 Financial Results PR Newswire HOLLISTON, Mass., Nov. 13, 2020 HOLLISTON, Mass. , Nov. 13, 2020 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a clinical-stage biotechnology company deve...
-
HOLLISTON, Mass. , Aug. 13, 2020 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a clinical-stage biotechnology company developing bioengineered organ implants based on the Company's novel Cellspan™ technology for the treatment of esopha...